AAAAAA
Results:
1-15
|
Results: 15
Authors:
Muschen, M
Kuppers, R
Spieker, T
Brauninger, A
Rajewsky, K
Hansmann, ML
Citation: M. Muschen et al., Molecular single-cell analysis of Hodgkin- and Reed-Sternberg cells harboring unmutated immunoglobulin variable region genes, LAB INV, 81(3), 2001, pp. 289-295
Authors:
Muschen, M
Re, D
Betz, B
Moers, C
Wolf, J
Niederacher, D
Diehl, V
Beckmann, MW
Citation: M. Muschen et al., Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene, INT J CANC, 92(2), 2001, pp. 309-310
Authors:
Re, D
Muschen, M
Ahmadi, T
Wickenhauser, C
Staratschek-Jox, A
Holtick, U
Diehl, V
Wolf, J
Citation: D. Re et al., Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells, CANCER RES, 61(5), 2001, pp. 2080-2084
Authors:
Kuppers, R
Brauninger, A
Muschen, M
Distler, V
Hansmann, ML
Rajewsky, K
Citation: R. Kuppers et al., Evidence that Hodgkin and Reed-Sternberg cells in Hodgkin disease do not represent cell fusions, BLOOD, 97(3), 2001, pp. 818-821
Authors:
Muschen, M
Warskulat, U
Beckmann, MW
Citation: M. Muschen et al., Defining CD95 as a tumor suppressor gene, J MOL MED-J, 78(6), 2000, pp. 312-325
Authors:
Muschen, M
Beckmann, MW
Citation: M. Muschen et Mw. Beckmann, CD95 ligand expression as a criterion of malignant transformation in breast cancer, J PATHOLOGY, 191(4), 2000, pp. 468-469
Authors:
Muschen, M
Re, D
Jungnickel, B
Diehl, V
Rajewsky, K
Kuppers, R
Citation: M. Muschen et al., Somatic mutation of the CD95 gene in human B cells as a side-effect of thegerminal center reaction, J EXP MED, 192(12), 2000, pp. 1833-1839
Authors:
Muschen, M
Rajewsky, K
Brauninger, A
Baur, AS
Oudejans, JJ
Roers, A
Hansmann, ML
Kuppers, R
Citation: M. Muschen et al., Rare occurrence of classical Hodgkin's disease as a T cell lymphoma, J EXP MED, 191(2), 2000, pp. 387-394
Authors:
Muschen, M
Moers, C
Warskulat, U
Even, J
Niederacher, D
Beckmann, MW
Citation: M. Muschen et al., CD95 ligand expression as a mechanism of immune escape in breast cancer, IMMUNOLOGY, 99(1), 2000, pp. 69-77
Authors:
Muschen, M
Re, D
Brauninger, A
Wolf, J
Hansmann, ML
Diehl, V
Kuppers, R
Rajewsky, K
Citation: M. Muschen et al., Somatic mutations of the CD95 gene in Hodgkin and Reed-Sternberg cells, CANCER RES, 60(20), 2000, pp. 5640-5643
Authors:
Muschen, M
Moers, C
Warskulat, U
Niederacher, D
Betz, B
Even, J
Lim, A
Josien, R
Beckmann, MW
Haussinger, D
Citation: M. Muschen et al., CD95 ligand expression in dedifferentiated breast cancer, J PATHOLOGY, 189(3), 1999, pp. 378-386
Authors:
Moers, C
Warskulat, U
Muschen, M
Even, J
Niederacher, D
Josien, R
Koldovsky, U
Beckmann, MW
Haussinger, D
Citation: C. Moers et al., Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin, INT J CANC, 80(4), 1999, pp. 564-572
Authors:
Muschen, M
Warskulat, U
Peters-Regehr, T
Bode, JG
Kubitz, R
Haussinger, D
Citation: M. Muschen et al., Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation, GASTROENTY, 116(3), 1999, pp. 666-677
Authors:
Muschen, M
Warskulat, U
Perniok, A
Even, J
Moers, C
Kismet, B
Temizkan, N
Simon, D
Schneider, M
Haussinger, D
Citation: M. Muschen et al., Involvement of soluble CD95 in Churg-Strauss syndrome, AM J PATH, 155(3), 1999, pp. 915-925
A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance
Authors:
Josien, R
Douillard, P
Guillot, C
Muschen, M
Anegon, I
Chetritt, J
Menoret, S
Vignes, C
Soulillou, JP
Cuturi, MC
Citation: R. Josien et al., A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance, J CLIN INV, 102(11), 1998, pp. 1920-1926
Risultati:
1-15
|